Gangliosides and autoimmune neuropathies: classification and clinical aspects of autoimmune neuropathies.
Open Access
- 1 November 1994
- journal article
- review article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 57 (Suppl) , 26-28
- https://doi.org/10.1136/jnnp.57.suppl.26
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Pathological findings at the site of conduction block in multifocal motor neuropathyAnnals of Neurology, 1993
- Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndromeAnnals of Neurology, 1992
- Plasma Exchange in Polyneuropathy Associated with Monoclonal Gammopathy of Undetermined SignificanceNew England Journal of Medicine, 1991
- Invited review: Motor neuropathies, motor neuron disorders, and antiglycolipid antibodiesMuscle & Nerve, 1991
- Immunosuppressive treatment in multifocal motor neuropathyAnnals of Neurology, 1991
- Predictive value of anti-GM1 ganglioside antibodies in neuromuscular diseases: a study of 180 seraJournal of Neuroimmunology, 1991
- The spectrum of neurologic disease associated with anti‐GM 1 antibodiesNeurology, 1990
- Measurement and significance of antibodies against GM1 ganglioside Report of a workshop, 18 April 1989, Chicago, IL, U.S.A.Journal of Neuroimmunology, 1989
- Peripheral neuropathy associated with monoclonal IgM autoantibodyAnnals of Neurology, 1987
- Myelin‐Associated Glycoprotein Is the Antigen for a Monoclonal IgM in PolyneuropathyJournal of Neurochemistry, 1982